Triple negative breast cancer (TNBC) is defined by the absence of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) and accounts for 12–15 % of all invasive breast cancer [3]. The gene discussed is PGR; the disease is triple-negative breast carcinoma.